We are a reputed organization that caters to the diversified requirements of health sector by manufacturing and exporting an exclusive range of Mycophenolate Sodium Tablets. These tablets are formulated under the firm observation of the expert professionals using high quality compounds, which we procure from the reputed vendors. To make sure that only defect free range is provided to the clients, we check the Mycophenolate Sodium Tablets on standard quality parameters. We offer our tablets at pocket friendly prices.
Long shelf life
For the prophylaxis of organ rejection in patients receiving allogeneic renal transplants.
Adults : 720 mg twice daily
Pediatrics : Based on a pharmacokinetic study conducted in stable renal pediatric transplant patients, the recommended dose in stable pediatric patients is 400 mg/m2 body surface area (BSA) administered twice daily (up to a maximum dose of 720 mg administered twice daily).
Dosage Adjustment :
Renal Impairment : Not required.
Hepatic Impairment : May be required in renal patients with some hepatic diseases.
Packing: 1 Strip of 10 Tablets
We also deals in:
|Name of the Product||Composition|
|Myotec-S 180mg Tablets||Mycophenolate Sodium 180mg|
|Myotec-S 360mg Tablets||Mycophenolate Sodium 360mg|
FC/B-1 (Extn.), Mohan Co-operative Industrial Estate, Mathura Road, New Delhi, Delhi, 110044, India